Certified by Founder Lodge
Edgewood Oncology
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $20,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Synergistically targeting the master regulators of cancer
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 26 ,2024 | Series A | $20,000,000 |
Alta Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Formulary Financial | $4,600,000 | (Jan 21, 2026)
BrightInsight | $13,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
Dam Secure | $4,000,000 | (Jan 21, 2026)
ErVimmune | $19,917,795 | (Jan 21, 2026)
